Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2024)
Whitehawk Therapeutics (WHWK) posted quarterly Interest Expenses of $8.1 million for Q1 2026, up 8050.51% year-over-year from $99000.0 in Q1 2025, and up 8250.51% quarter-over-quarter from -$99000.0 in Q4 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Interest Expenses for 17 consecutive years, with $8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 8050.51% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (up 1431.12% YoY), while the FY2025 annual figure was $3.2 million, down 97.37% from the prior year.
- Interest Expenses climbed to $8.1 million in Q1 2026 per WHWK's latest filing, from -$99000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $8.1 million in Q1 2026 and bottomed at -$144000.0 in Q4 2023.
- Historically, Interest Expenses has averaged $980176.5 across 5 years, with a median of $280000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses sank 352.63% — and 2026, when it jumped 8050.51%.
- Whitehawk Therapeutics' Interest Expenses stood at $57000.0 in 2022, then tumbled by 352.63% to -$144000.0 in 2023, then soared by 409.72% to $446000.0 in 2024, then plunged by 122.2% to -$99000.0 in 2025, then soared by 8250.51% to $8.1 million in 2026.
- Business Quant data shows WHWK's Interest Expenses at $8.1 million in Q1 2026, -$99000.0 in Q4 2025, and $539000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Dec 31, 2020 | 230,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Dec 31, 2016 | 2,571.00 |
| Sep 30, 2016 | 2,434.00 |
| Jun 30, 2016 | 2,543.00 |